CN1138551C - 上皮粘附性乳杆菌 - Google Patents

上皮粘附性乳杆菌 Download PDF

Info

Publication number
CN1138551C
CN1138551C CNB961940867A CN96194086A CN1138551C CN 1138551 C CN1138551 C CN 1138551C CN B961940867 A CNB961940867 A CN B961940867A CN 96194086 A CN96194086 A CN 96194086A CN 1138551 C CN1138551 C CN 1138551C
Authority
CN
China
Prior art keywords
mannose
lactobacillus
bacteria
strains
lactobacillus plantarum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB961940867A
Other languages
English (en)
Chinese (zh)
Other versions
CN1185111A (zh
Inventor
I�����ձ�˹
I·阿勒堡斯
S·阿尔内
�������ɭ
B·耶普森
��Ǻ�ɭ
M·－L·乔汉森
G·莫林
A·沃尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Probi AB
Original Assignee
Probi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi AB filed Critical Probi AB
Publication of CN1185111A publication Critical patent/CN1185111A/zh
Application granted granted Critical
Publication of CN1138551C publication Critical patent/CN1138551C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CNB961940867A 1995-03-23 1996-03-25 上皮粘附性乳杆菌 Expired - Lifetime CN1138551C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501056A SE9501056D0 (sv) 1995-03-23 1995-03-23 Epithelial adherent lactobacilli
SE95010567 1995-03-23

Publications (2)

Publication Number Publication Date
CN1185111A CN1185111A (zh) 1998-06-17
CN1138551C true CN1138551C (zh) 2004-02-18

Family

ID=20397666

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB961940867A Expired - Lifetime CN1138551C (zh) 1995-03-23 1996-03-25 上皮粘附性乳杆菌

Country Status (16)

Country Link
US (1) US6159465A (https=)
EP (1) EP0817640B1 (https=)
JP (1) JP4072646B2 (https=)
KR (1) KR100446482B1 (https=)
CN (1) CN1138551C (https=)
AT (1) ATE240738T1 (https=)
AU (1) AU702705B2 (https=)
BR (1) BR9607538A (https=)
CA (1) CA2216150C (https=)
DE (1) DE69628288T2 (https=)
EE (1) EE04097B1 (https=)
ES (1) ES2200057T3 (https=)
NO (1) NO974371L (https=)
PL (1) PL184037B1 (https=)
SE (1) SE9501056D0 (https=)
WO (1) WO1996029083A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
JP2002507997A (ja) * 1997-07-05 2002-03-12 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 腸管細胞によるミネラルの吸収
FI974643L (fi) * 1997-12-30 1999-07-01 Atria Oyj Biologinen menetelmä salmonellan eliminoimiseksi prosesseista ja rakenteista
US6830750B1 (en) * 1998-10-01 2004-12-14 Probi Ab Reduction of oxidative stress factors with Lactobacillus plantarum
CA2378620A1 (en) * 1999-08-09 2001-02-15 Pinaki Panigrahi Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
AP1563A (en) 1999-10-26 2006-02-02 Nestle Sa Lactic acid bacteria for the treatment and /or prophylaxis of giardiasis.
GB2369777B (en) * 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
SE0004124D0 (sv) * 2000-11-10 2000-11-10 Probi Ab New use
CA2450444A1 (fr) * 2001-06-14 2002-12-27 Ceva Sante Animale Procede de selection de souches de bacteries lactiques a gram positif non pathogenes
FR2831555A1 (fr) * 2001-10-29 2003-05-02 Ceva Sante Animale Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes
FR2826020B1 (fr) * 2001-06-14 2005-02-11 Ceva Sante Animale Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2005086870A2 (en) * 2004-03-10 2005-09-22 The Board Of Trustees Of The University Of Illinois Novel lactobacillus strains and method of use
EP1730179B1 (en) * 2004-03-23 2010-04-28 Friesland Brands B.V. Novel mannose-specific adhesins and their use
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
JP2006180836A (ja) * 2004-12-28 2006-07-13 Marudai Food Co Ltd 食中毒菌感染を抑制する乳酸菌、ならびにそれを含む発酵物、食品および医薬組成物
JP2006257077A (ja) * 2005-02-18 2006-09-28 Marudai Food Co Ltd 免疫調節剤および免疫調節食品
CN1888051B (zh) * 2005-06-28 2010-05-05 北京天佑达生物工程科技有限公司 一株植物乳杆菌及其应用
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption
EP1931363B1 (en) 2005-09-28 2015-11-18 Nordisk Rebalance A/S Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors
KR101397386B1 (ko) 2005-12-13 2014-05-26 엑스테라 메디컬 코퍼레이션 혈액으로부터 병원성 미생물, 염증 세포 또는 염증단백질의 체외 제거를 위한 방법
PL210465B1 (pl) 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
FR2928935B1 (fr) 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
EP2459203B1 (en) 2009-07-30 2018-10-31 DuPont Nutrition Biosciences ApS Lactic acid bacteria and bifidobacteria for treating endotoxemia
ES2861359T3 (es) 2009-12-01 2021-10-06 Exthera Medical Corp Dispositivo para eliminar citoquinas de la sangre con polisacáridos inmovilizados en superficie
CN102905712B (zh) 2010-01-28 2015-12-16 Ab－生物学有限公司 用于治疗肠炎的益生菌组合物
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
BG66608B1 (bg) * 2011-05-04 2017-10-16 "Ел Би Булгарикум" ЕАД Полибактериален пробиотичен препарат
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
EP2861273B1 (en) 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
JP2012184261A (ja) * 2012-06-21 2012-09-27 Snow Brand Milk Products Co Ltd 免疫増強剤
CN102827796B (zh) * 2012-09-03 2013-10-30 江南大学 一种具有排镉功能的植物乳杆菌及其用途
EP2897638A1 (en) 2012-09-24 2015-07-29 Montana State University-Bozeman Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use
BR112015032134B1 (pt) 2013-06-24 2022-05-10 Exthera Medical Corporation Método de ligação em ponto de extremidade de uma manose não redutora a um substrato e esfera possuindo uma manose ligada em ponto de extremidade
BR112016009827B1 (pt) 2013-11-08 2021-10-26 Exthera Medical Corporation Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit
EP3134146B1 (en) 2014-04-24 2024-12-25 ExThera Medical Corporation Method for removing bacteria from blood using high flow rate
US10857283B2 (en) 2014-09-22 2020-12-08 Exthera Medical Corporation Wearable hemoperfusion device
CN108235682A (zh) 2015-09-29 2018-06-29 金伯利-克拉克环球有限公司 用于维护微生物群落的健康平衡的协同组合物
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
KR102769558B1 (ko) 2017-02-28 2025-02-19 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승적 조성물
KR102024883B1 (ko) 2017-11-24 2019-09-24 주식회사 고바이오랩 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도
MY202164A (en) 2018-05-09 2024-04-09 Kobiolabs Inc Lactobacillus paracasei strain and use thereof
KR102138834B1 (ko) 2018-05-23 2020-07-29 주식회사 고바이오랩 락토바실러스 가세리 kbl697 균주 및 그 용도
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure
MY199150A (en) 2019-06-05 2023-10-18 Morinaga Milk Industry Co Ltd Nutritional composition
CN111575223B (zh) * 2020-05-20 2022-04-15 江南大学 一种降低鼠李糖乳杆菌表面物质分泌量的方法
CN119242500A (zh) * 2024-09-30 2025-01-03 尚品健康科技(青岛)有限公司 一株母乳来源植物乳植杆菌改善过敏性疾病和调节肠道菌群的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203586A3 (en) * 1985-05-29 1988-03-09 Pioneer Hi-Bred International A composition for treating gastrointestinal disease in animals
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
GB9124249D0 (en) * 1991-11-14 1992-01-08 Goldstein Fredric Ribbon curling and shredding device
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection

Also Published As

Publication number Publication date
SE9501056D0 (sv) 1995-03-23
CA2216150A1 (en) 1996-09-26
BR9607538A (pt) 1998-01-06
EE04097B1 (et) 2003-08-15
WO1996029083A1 (en) 1996-09-26
NO974371L (no) 1997-11-20
PL322550A1 (en) 1998-02-02
ATE240738T1 (de) 2003-06-15
EE9700329A (et) 1998-06-15
CA2216150C (en) 2008-01-22
NO974371D0 (no) 1997-09-22
EP0817640B1 (en) 2003-05-21
PL184037B1 (pl) 2002-08-30
CN1185111A (zh) 1998-06-17
KR100446482B1 (ko) 2006-01-27
EP0817640A1 (en) 1998-01-14
AU702705B2 (en) 1999-03-04
AU5166596A (en) 1996-10-08
ES2200057T3 (es) 2004-03-01
DE69628288T2 (de) 2004-04-08
DE69628288D1 (de) 2003-06-26
JPH11502703A (ja) 1999-03-09
HK1017989A1 (en) 1999-12-10
KR19980703102A (ko) 1998-10-15
JP4072646B2 (ja) 2008-04-09
US6159465A (en) 2000-12-12

Similar Documents

Publication Publication Date Title
CN1138551C (zh) 上皮粘附性乳杆菌
CN100378214C (zh) 益生细菌:发酵乳杆菌
CN1153575C (zh) 包含鼠李糖乳杆菌的药物制剂
TWI417054B (zh) 新穎糞腸球菌ｌｊｓ－０１及其益生用途
US20080131401A1 (en) Alteration of microbial populations in the gastrointestinal tract
SK280682B6 (sk) Bifidobaktérie a ich použitie
WO2006038869A1 (en) Probiotic lactobacillus strains for improved vaginal health
JP2004523241A (ja) プロバイオティクスとして有用な新規ラクトバチルス・ロイテリ（Ｌａｃｔｏｂａｃｉｌｌｕｓｒｅｕｔｅｒｉ）
KR20010071416A (ko) 유산균 함유 조성물, 약품 및 식품
JP2002534113A (ja) 炎症性疾患治療におけるビフィドバクテリウム（Ｂｉｆｉｄｏｂａｃｔｅｒｉｕｍ）
CN113832077A (zh) 鼠李糖乳杆菌及其应用
CN118792213A (zh) 植物乳植杆菌msjk0048及其在降血脂中的应用
Anjum et al. Potentially probiotic Limosilactobacillus reuteri from human milk strengthens the gut barrier in T84 cells and a murine enteroid model
KR100574527B1 (ko) 면역활성이 높고 항암효과 및 유해 미생물 증식 억제활성이 뛰어난 신규 내산성 락토바실러스 사케이 Probio-44
KR102808726B1 (ko) 프럭토필릭 락트산 생산 박테리아
KR20050041808A (ko) 항암효과 및 항균활성이 뛰어난 신규 유산균 류코노스톡시트리움 km20
EP3035945B1 (en) A probiotic composition comprising the novel isolated bacterial strain of brevibacterium casei ap9
Mandal et al. Therapeutic potential of Lactobacillus ingluviei ADK10, a newly established probiotic organism against acetaminophen induced uremic rats
HK1017989B (zh) 上皮粘附性乳杆菌
TWI819484B (zh) 合益素組成物及其用於製備抑制抗藥性腸桿菌之口服組成物的用途
TWI819483B (zh) 乳酸菌組成物及其用於製備抑制抗藥性腸桿菌之口服組成物的用途
RU2771136C1 (ru) Штамм Meyerozyma (Pichia) guilliermondii (варианты), используемый для изготовления пре-, про- и аутопробиотических препаратов и продуктов для человека и животных, лечебно-профилактическое средство на его основе и способ его получения (варианты)
CN118652813A (zh) 一株海氏肠球菌及其应用
CN121406534A (zh) 一株具有缓解腹泻的乳双歧杆菌bl-pg-09菌株及其制备方法
Macfarlane et al. and Biofilms in the Large Bowel

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20040218

EXPY Termination of patent right or utility model